Repligen Corporation (RGEN) vs Solventum Corporation (SOLV)
- Repligen Corporation RGEN 175.20 −4.87%
- Solventum Corporation SOLV 85.81 −2.33%
Repligen Corporation and Solventum Corporation are both Medical Instruments & Supplies companies. Solventum Corporation is the larger, with a market value of $15.0B against $11.7B — 1.3× the size. Solventum Corporation trades at the lower P/E: 10.4× against 234×. Repligen Corporation grew revenue faster over the last twelve months: 16.5% against −0.93%. Solventum Corporation has the higher net margin (17.3% vs 5.29%) and the higher return on invested capital (13.4% vs 2.18%). Across the 19 metrics below, Solventum Corporation leads on 12 and Repligen Corporation on 7.
Valuation
Profitability
| Metric | RGEN | SOLV | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 53.52% | 54.68% | 54.29% |
| Operating margin | 8.23% | 24.98% | 1.07% |
| Net margin | 5.29% | 17.26% | (1.61%) |
| Free cash flow margin | 14.06% | (1.42%) | 1.08% |
| Return on equity | 1.99% | 33.96% | (1.32%) |
| Return on assets | 1.42% | 9.78% | 0.00% |
| Return on invested capital | 2.18% | 13.40% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack